Patent · US Active

Neutral nanotransporters

US11396654B2 · kind B2 · utility

3Cited by

0References

19Claims

0Family size

Assignee

Phio Pharmaceuticals Corp. · US

Inventors

Anastasia Khvorova · Boulder, US
William Salomon · Worcester, US
Joanne Kamens · Newton, US
Dmitry Samarsky · Berlin, DE
Tod M. Woolf · Sudbury, US
Michelle Miller · East Walpole, US
Karen G. Bulock · Mendon, US

Key dates

Filing date	Oct 12, 2018
Grant date	Jul 26, 2022
Priority date	—
Expiry date	Oct 12, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/53
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Neutral lipid formulations for nucleic acid delivery are provided according to the invention. The neutral lipid formulations include hydrophobically modified polynucleotides and fat mixtures. Methods of using the neutral lipid formulations are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.